UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
57 hedge funds and large institutions have $133M invested in Unity Biotechnology in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+2
Holders Change %
+3.64%
% of All Funds
1.24%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
23
Reduced
11
Closed
11
Calls
–
Puts
$97K
Net Calls
-$97K
Net Calls Change
-$97K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.68M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$3.03M |
| 3 |
Morgan Stanley
New York
|
+$3.02M |
| 4 |
Millennium Management
New York
|
+$693K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$405K |
